Patent · US Active

Substituted-1,3,8-triazaspiro[4.5]decane-2,4-diones

US8921555B2 · kind B2 · utility

1Cited by
3References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 7, 2010
Grant dateDec 30, 2014
Priority date—
Expiry dateJun 7, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D471/10
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to substituted 1,3,8-triazaspiro[4.5]decame-2,4-diones useful as HIF prolyl hydroxylase inhibitors to treat anemia and like conditions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.